Compare GSK plc (GSK) vs Clear Secure Inc (YOU) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
GSK plc vs Clear Secure Inc — how do they compare? GSK plc trades at $46.5 (market cap $91.88B), while Clear Secure Inc trades at $43.43 (market cap $4.44B). The key difference: GSK plc is far larger — about 20.7× Clear Secure Inc's market cap, and GSK plc pays the higher dividend (3.9%). Which is the better fit depends on your goals — on Pluang, investors hold GSK plc for 93 Days and Clear Secure Inc for 19 Days on average.
| GSK | YOU | |
|---|---|---|
Market Cap | $91.88B | $4.44B |
Volume | 7,730,529 | 1,477,828 |
Sector | Health | Technology |
52-Week High | $61.18 | $62.36 |
52-Week Low | $43.24 | $29.61 |
Typical Hold Time | 93 Days | 19 Days |
Enterprise Value | $111.88B | $3.59B |
Dividend Yield | 3.9% | 1.33% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
GSK trades at $46.54, down 1.02% with bearish technical signals but strong fundamentals including 29.73% ROE and consistent earnings beats. The company maintains robust profitability with 72.73% gross margins and is actively expanding its oncology pipeline through strategic partnerships. Recent developments include a $750M cancer therapy acquisition and advancing mRNA vaccine candidates.
GSK presents a mixed outlook with strong operational performance offset by technical weakness. Investment appeal lies in valuation multiples below industry averages and pipeline expansion, though risks include HIV patent expirations and manufacturing restructuring. Analyst consensus leans cautious with 55% hold ratings amid near-term headwinds.
Clear Secure (YOU) trades at $43.08, up 1.17% on the day, with a bullish technical signal despite mixed moving averages. The company reported strong Q2 2026 results, beating EPS estimates with $0.49 versus $0.3967 expected, and revenue growth accelerated to 27% year-over-year. Analyst consensus is a Buy with a $61.40 price target, implying significant upside. Recent news highlights strategic partnerships, including integration with CrowdStrike's Falcon platform, and the launch of corporate membership programs.
The outlook for YOU is positive, driven by robust membership growth, expanding profit margins, and strategic initiatives. Key risks include execution challenges in new enterprise offerings, competitive pressures in identity verification, and sensitivity to travel industry trends. The stock's high P/E of 29.11 and P/B of 21.5 reflect growth expectations but warrant monitoring for sustainability amid market volatility.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About GSK plc
In the pharmaceutical industry, GSK ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, cancer, and antiviral, as well as vaccines. GSK uses joint ventures to gain additional scale in certain markets like HIV.
Read more on GSK →About Clear Secure Inc
Clear Secure operates a secure identity platform that uses biometrics—specifically eyes, face, and fingerprints—to automate and expedite identity verification. While its most visible application is the CLEAR Plus airport subscription service, the company functions as a broad-based identity layer for travel, healthcare, and digital services, aiming to replace physical IDs with a secure, biometric link.
Read more on YOU →
